	Surgical Management of PSMA PET-Positive Lymph Nodes in Prostate Cancer. Curr Urol Rep Cosenza A, Quarta L, Galdieri A, Brancaccio M, Occhi A, Porzi ME, Zaurito P, Viti A, Santangelo A, Scilipoti P, Scuderi S, Barletta F, Stabile A, Montorsi F, Briganti A, Gandaglia G. PMID: 42518100 [PubMed - as supplied by publisher]
	Impact of central review and MRI image quality on prostate cancer diagnosis and biopsy decision-making in referred patients. Abdom Radiol (NY) Zheng Z, Liu Y, Wu S, Chen Y, Jin P, Shi L, Zhang G, Sun H, Wang X, Xu L. PMID: 42517901 [PubMed - as supplied by publisher]
	Use of whole-body MRI to evaluate residual tumour burden after initial systemic therapy in polymetastatic hormone-sensitive prostate cancer. Br J Radiol Thompson C, Withey SJ, Tunariu N, Parker C, Tree A, Reid A, Pathmanathan A, Murray J. PMID: 42517815 [PubMed - as supplied by publisher]
	Erratum for: (61)Cu-NODAGA Prostate-specific Membrane Antigen Imaging and Therapy for Prostate Cancer: Phase 1 Trial of a New Class of (61)Cu-labeled PET Radiotracers. Radiology Ulaner GA, Bassett JC, Reddy R, Thomsen B, Reynolds D, Jerjian KJ, Wolfe R, Benjamin DJ, Fani M, O'Donoghue J, Baier M, Schubert N, Pais B, De Rose F, Jaafar L. PMID: 42517773 [PubMed - as supplied by publisher]
	Combination of Radiation Therapy and Irreversible Electroporation for Intermediate-Risk Prostate Cancer (RTIRE): A Phase 1 Trial. Radiology McClure TD, Wang S, Ballman KV, Diven M, Osborne JR, O'Dwyer E, Piscopo J, Khani F, Marciscano A, Al Hussein Al Awamlh B, Barbieri C, Nagar H. PMID: 42517770 [PubMed - as supplied by publisher]
	Tumor-associated macrophages and lineage plasticity in prostate cancer: from established myeloid programs to emerging spatial hypotheses. Front Immunol Li J, Li J, Zhao Y, Yu Y, Cui X. PMID: 42516385 [PubMed - as supplied by publisher]
	Innovations in Diagnosis Immunotherapy and Combination Therapy of Prostate Cancer: A Patent-driven Analysis. Recent Pat Anticancer Drug Discov Relan R, Sambar B, Dudam AK, Kanugo A. PMID: 42515880 [PubMed - as supplied by publisher]
	INtraVESical immunoTherapy (INVEST) prior to radical cystectomy for bladder cancer: trial protocol. BJU Int Lister-Whelan R, Senior E, Kendall J, Oughton JB, Collinson F, Griffin J, Hubbard R, Kennish S, Noon A, Rosario DJ, Riaz IB, Telliez J, Catto JWF, Hussain SA. PMID: 42515859 [PubMed - as supplied by publisher]
	Preclinical Models of Bladder Cancer: Barrier, Metabolic, and Translational Susceptibility. Pharmaceuticals (Basel) Liu T, Li W, Yin Q, Liu D, Wang Y, Cui N. PMID: 42515797 [PubMed - as supplied by publisher]
	Feasibility and Acceptability of a Group-Based Telehealth Stress Management and Resilience Training Intervention for Men with Prostate Cancer on Active Surveillance. J Clin Med Mohamed NE, Noel JC, Scharp D, Fu W, Joshi H, Korn T, Johnson I, Tewari A, Gonzalez A. PMID: 42513453 [PubMed - as supplied by publisher]
	CT-Based Radiomics for Prediction of Molecular Markers in Clear Cell Renal Cell Carcinoma: A Comprehensive Review. Medicina (Kaunas) Boukali E, Koumpis P, Romeo E, Vartholomatos E, Alexiou GA, Argyropoulou MI, Tsili AC. PMID: 42512891 [PubMed - as supplied by publisher]
	Theranostic Potential of (177)Lu-TLX591 with Best Standard-of-Care and (68)Ga-PSMA-11 PET for Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the Phase 1 ProstACT SELECT Trial. Cancers (Basel) Lenzo N, O'Byrne K, Ngai S, Krieger L, Wong V, Cade DN. PMID: 42512394 [PubMed]
	Low-Cost Pathology Signals for Risk Stratification in High-Risk Non-Muscle-Invasive Bladder Cancer: A Narrative Review. Cancers (Basel) Sala-González N, Chekhun S, Fina C, Vilaseca M, Rossylna O, Boix R, Bella-Burgos B, Comet J. PMID: 42512334 [PubMed - as supplied by publisher]
	Robot-Assisted Versus Open Nephrectomy with Inferior Vena Cava Thrombectomy in Renal Cell Carcinoma: Current Evidence and Surgical Trends. Cancers (Basel) Korbecka Z, Jab, Król R. PMID: 42512316 [PubMed - as supplied by publisher]
	Early Post-Treatment Eosinophil Elevation and Survival Outcomes in Metastatic Renal Cell Carcinoma Treated with First-Line VEGFR-TKI Monotherapy: A Turkish Multicenter Retrospective Cohort Study. Biomedicines Aktepe OH, Rustamov S, Izgor RB, Butun O, Karakaya S, Ulasli T, Yalcin S. PMID: 42512093 [PubMed - as supplied by publisher]
	Serum CCL2 and CCL7 in Prostate Cancer: Evaluation of Their Diagnostic Utility in Comparison with Benign Prostatic Hyperplasia and Healthy Controls. Int J Mol Sci Sokólska W, Zajkowska M, Nowi, Orywal K. PMID: 42511541 [PubMed - as supplied by publisher]
	A Network Pharmacology Review of Plant-Derived Anticancer Compounds in Lung, Breast, Colorectal and Prostate Cancer. Int J Mol Sci Merecz-Sadowska A, Sadowski A, Zajdel K, J, Sitarek P, Zajdel R. PMID: 42511521 [PubMed - as supplied by publisher]
	The Oncogenic Role of Prostate Stem Cell Antigen (PSCA) in Colorectal Cancer: Implications for Targeted Therapy. Curr Issues Mol Biol Duan J, Wang Y, Li Q, Wang Y, Liu J, Qi Y, Zhang Y, Fu C, Cong Z, Wang C, Su M. PMID: 42510977 [PubMed - as supplied by publisher]
	SnoRNA and SNHG in Bladder Cancer: Molecular Mechanisms and Clinical Significance. Curr Issues Mol Biol Gimalova G, Gilyazova I, Khusnutdinova E, Pavlov V. PMID: 42510903 [PubMed - as supplied by publisher]
	Recent Advances in Multimodal Assessment Scoring Systems for Prostate Cancer: An Integrated Pathological and Imaging Perspective. Diagnostics (Basel) Zhang X, Wang C. PMID: 42510039 [PubMed - as supplied by publisher]

Articles 1 - 20 / 180339

Page 1 of 9017



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy